Citations

Clear

4610 citation(s) found for "Lu, Brian".

Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies
Hendrickson, Andrea E. Wahner , Yun, Seong Seok, Han, Jing, Schneider, Paula A., Koh, Brian D. , Stenson, Mary, Wellik, Linda, Shing, Jennifer C. , Peterson, Kevin L. , Flatten, Karen S., Hess, Allan D., Karp, Judith E. , Barr, Sharon, Gupta, Mamta , Smith, B. Douglas , Witzig, Thomas E. , Kaufmann, Scott H.

Mayo Clinic

Blood | November 12, 2011 | Volume: 119 | Issue: 2 | Pages: 476-487

10.1182/blood-2011-04-346601 | PMID 22080480 Get It

Abstract The mammalian target of rapamycin (mTOR) plays crucial roles in proliferative and antiapoptotic signaling in lymphoid malignancies. Rapamycin analogs, which are allosteric mTOR complex 1 (mTORC1) inhibitors, are active in mantle cell lymphoma and other lymphoid neoplasms, but responses are usually partial and short-lived. In the present study we compared the effects of rapamycin with the dual mTORC1/mTORC2 inhibitor OSI-027 in cell lines and clinical samples representing divers lymphoid malignancies. In contrast to rapamycin, OSI-027 markedly diminished proliferation and induced apoptosis in a variety of lymphoid cell lines and clinical samples, including specimens of B-cell acute lymphocytic leukemia (ALL), mantle cell lymphoma, marginal zone lymphoma and Sezary syndrome. Additional analysis demonstrated that OSI-027–induced apoptosis depended on transcriptional activation of the PUMA and BIM genes. Overexpression of Bcl-2, which neutralizes Puma and Bim, or loss of procaspase 9 diminished OSI-027–induced apoptosis in vitro. Moreover, OSI-027 inhibited phosphorylation of mTORC1 and mTORC2 substrates, up-regulated Puma, and induced regressions in Jeko xenografts. Collectively, these results not only identify a pathway that is critical for the cytotoxicity of dual mTORC1/mTORC2 inhibitors, but also suggest that simultaneously targeting mTORC1 and mTORC2 might be an effective anti-lymphoma strategy in vivo.
Radiographic Sizing for Meniscal Transplantation Using 3-D CT Reconstruction
McConkey, Mark O., Lyon, Craig, Bennett, D. Lee , Schoch, Bradley S. , Britton, Carla , Amendola, Annunziato , Wolf, Brian R. , Schoch, Bradley S

Mayo Clinic

Journal of Knee Surgery | October 28, 2011 | Volume: 25 | Issue: 03 | Pages: 221-226

10.1055/s-0031-1292651 | PMID 23057141 Get It

Temporal Lobe Epilepsy in Children
Moseley, Brian D. , Nickels, Katherine , Wong‐Kisiel, Lily C. , Wirrell, Elaine

Mayo Clinic

Epilepsy Research and Treatment | October 20, 2011 | Volume: 2012 | Issue: No issue available | Pages: 1-16

10.1155/2012/849540 | PMID 22957247 Get It

The temporal lobe is a common focus for epilepsy. Temporal lobe epilepsy in infants and children differs from the relatively homogeneous syndrome seen in adults in several important clinical and pathological ways. Seizure semiology varies by age, and the ictal EEG pattern may be less clear cut than what is seen in adults. Additionally, the occurrence of intractable seizures in the developing brain may impact neurocognitive function remote from the temporal area. While many children will respond favorably to medical therapy, those with focal imaging abnormalities including cortical dysplasia, hippocampal sclerosis, or low-grade tumors are likely to be intractable. Expedient workup and surgical intervention in these medically intractable cases are needed to maximize long-term developmental outcome.
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
Jagasia, Madan , Arora, Mukta , Urbano-Ispizúa, Álvaro , Pavletic, Steven Z. , Haagenson, Michael , Zhang, Mei-Jie , Antin, Joseph H. , Bolwell, Brian J., Bredeson, Christopher , Cahn, Jean‐Yves, Cairo, Mitchell S. , Gupta, Vikas , Lee, Stephanie J. , Litzow, Mark R. , Weisdorf, Daniel J. , Horowitz, Mary M. , Hahn, Theresa , Flowers, Mary E.D. , Chao, Nelson J. , McCarthy, Philip L. , Cutler, Corey S. , Gale, Robert Peter , Weisdorf, Dan , Gupta, Vikas , Lee, Stephanie J

Mayo Clinic

Blood | October 19, 2011 | Volume: 119 | Issue: 1 | Pages: 296-307

10.1182/blood-2011-06-364265 | PMID 22010102 Get It

Abstract Risk factors for acute GVHD (AGVHD), overall survival, and transplant-related mortality were evaluated in adults receiving allogeneic hematopoietic cell transplants (1999-2005) from HLA-identical sibling donors (SDs; n = 3191) or unrelated donors (URDs; n = 2370) and reported to the Center for International Blood and Marrow Transplant Research, Minneapolis, MN. To understand the impact of transplant regimen on AGVHD risk, 6 treatment categories were evaluated: (1) myeloablative conditioning (MA) with total body irradiation (TBI) + PBSCs, (2) MA + TBI + BM, (3) MA + nonTBI + PBSCs, (4) MA + nonTBI + BM, (5) reduced intensity conditioning (RIC) + PBSCs, and (6) RIC + BM. The cumulative incidences of grades B-D AGVHD were 39% (95% confidence interval [CI], 37%-41%) in the SD cohort and 59% (95% CI, 57%-61%) in the URD cohort. Patients receiving SD transplants with MA + nonTBI + BM and RIC + PBSCs had significantly lower risks of grades B-D AGVHD than patients in other treatment categories. Those receiving URD transplants with MA + TBI + BM, MA + nonTBI + BM, RIC + BM, or RIC + PBSCs had lower risks of grades B-D AGVHD than those in other treatment categories. The 5-year probabilities of survival were 46% (95% CI, 44%-49%) with SD transplants and 33% (95% CI, 31%-35%) with URD transplants. Conditioning intensity, TBI and graft source have a combined effect on risk of AGVHD that must be considered in deciding on a treatment strategy for individual patients.
The Transcriptional Coactivator Cbp Regulates Self-Renewal and Differentiation in Adult Hematopoietic Stem Cells
Chan, Wai-In, Hannah, Rebecca , Dawson, Mark A. , Foster, Donna, Joshi, Anagha , Göttgens, Berthold , Deursen, Jan M. van , Huntly, Brian J.P. , Pridans, Clare

Mayo Clinic

Molecular and Cellular Biology | October 18, 2011 | Volume: 31 | Issue: 24 | Pages: 5046-5060

10.1128/mcb.05830-11 | PMID 22006020 Get It

Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica
Iorio, Raffaele , Lucchinetti, Claudia F. , Lennon, Vanda A. , Costanzi, Chiara, Hinson, Shannon R., Weinshenker, Brian G. , Pittock, Sean J. , Pittock, S J , Weinshenker, Brian G , Iorio, Raffaele

Mayo Clinic

Neurology | October 14, 2011 | Volume: 77 | Issue: 17 | Pages: 1644-1646

10.1212/wnl.0b013e3182343377 | PMID 21998320 Get It

Using Simulation to Design and Improve an Outpatient Procedure Center
Huschka, Todd R., Rohleder, Thomas R., Denton, Brian T.

Mayo Clinic

Management Engineering for Effective Healthcare Delivery | October 4, 2011 | Volume: No volume available | Issue: No issue available | Pages: 216-228

10.4018/978-1-60960-872-9.ch010 Get It

Discrete-event simulation (DES) is an effective tool to for analyzing and improving healthcare processes. In this chapter we discuss the use of simulation to improve patient flow at an outpatient procedure center (OPC) at Mayo Clinic. The OPC addressed is the Pain Clinic, which was faced with high patient volumes in a new, untested facility. Simulation was particularly useful due to the uncertain patient procedure and recovery times. We discuss the simulation process and show how it helped reduce patient waiting time while ensuring the clinic could meet its target patient volumes.
Intensive Care Unit Operational Modeling and Analysis
Dong, Yue , Lu, Huitian, Pickering, Brian W. , Gajic, Ognjen , Dong, Yue

Mayo Clinic

Management Engineering for Effective Healthcare Delivery | October 4, 2011 | Volume: No volume available | Issue: No issue available | Pages: 132-147

10.4018/978-1-60960-872-9.ch006 Get It

The outcome of critical illness depends not only on life threatening pathophysiologic disturbances, but also on several complex “system” dimensions: health care providers’ performance, organizational factors, environmental factors, family preferences and the interactions between each component. Systems engineering tools offer a novel approach which can facilitate a “systems understanding” of patient-environment interactions enabling advances in the science of healthcare delivery. Due to the complexity of operations in critical care medicine, certain assumptions are needed in order to understand system behavior. Patient variation and uncertainties underlying these assumptions present a challenge to investigators wishing to model and improve health care delivery processes. In this chapter we present a systems engineering approach to modeling critical care delivery using sepsis resuscitation as an example condition.
Learning Curve of Robotic-Assisted Microvascular Anastomosis in the Rat
Mattar, Tiago Guedes da Motta , Parisi, Thomas J., Carlsen, Brian T. , Shin, Alexander Y. , Lee, Joo‐Yup , Bishop, Allen T. , Shin, Alexander Y

Mayo Clinic

Journal of Reconstructive Microsurgery | September 30, 2011 | Volume: 28 | Issue: 07 | Pages: 451-456

10.1055/s-0031-1289166 | PMID 21959547 Get It

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine
Varon, SF, Grosberg, Brian M. , McAllister, Peter J., Freitag, F. G., Aurora, SK, Silberstein, Stephen D., DeGryse, Ronald E., Nolan, Marissa E., Turkel, Catherine C., Lipton, Richard B. , Dodick, David W. , Diener, Hans‐Christoph

Mayo Clinic

Neurology | September 29, 2011 | Volume: 77 | Issue: 15 | Pages: 1465-1472

10.1212/wnl.0b013e318232ab65 | PMID 21956721 Get It